Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Oct 29:7:101.
doi: 10.1186/s13048-014-0101-7.

Borderline Brenner tumor of the ovary: a case report with immunohistochemical and molecular study

Affiliations
Case Reports

Borderline Brenner tumor of the ovary: a case report with immunohistochemical and molecular study

Rossella De Cecio et al. J Ovarian Res. .

Abstract

Background: Borderline Brenner tumor of the ovary is a rare entity characterized by papillary structures with a fibro-vascular core, covered by a transitional epithelium, and by the absence of stromal infiltration. It is associated, by definition, with a benign component of Brenner tumor.

Case: We report a case of a 68-year-old woman, with a right ovarian mass, whose morphology and immuno-profile were consistent with the diagnosis of a borderline Brenner tumor. Immunohistochemistry carried out on selected markers may help to formulate the diagnosis, more than the molecular analyses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Contrast-enhanced CT scan showing a complex and heterogeneous pelvic mass with inner vegetations and septations in the anatomic site of the right adnexa (max diameter 17 cm), not dissociable from uterus and contiguous bowel (asterisk: pelvic mass; arrows: vegetations and septations; u: uterus).
Figure 2
Figure 2
Gross and microscopic description of Brenner tumor: a) Ovarian mass with solid papillary component; b) H & E representative of a solid adeno-fibromatous component (5X); c) H & E representative of cystic formations lined by mucinous columnar epithelium and by papillary transitional cellular component (10X); d) H & E representative of transitional epithelial cells with pale cytoplasm, indented nuclei and mild nuclear atypia (40X).
Figure 3
Figure 3
Borderline Brenner tumor immunoprofile. a) positive immunostaining for CK7 (10X); b) positive immunostaining for EMA (10X); c) positive immunostaining for thrombomodulin (20X); d) positive immunostaining for EGFR (20X); e) positive immunostaining for p16 (40X); f) positive immunostaining for p63 (20X).
Figure 4
Figure 4
EGFR molecular analyses. a) Absence of mutations detected by RT-PCR method (the yellow increased curves indicate the internal controls of the kit, the blue flat lines indicate our sample); b) Absence of chromosomal aberrations detected by FISH method (red signals represent the EGFR gene and green signals represent the centromeric sequence in chromosome 7. The above picture shows a balanced disomy (each nucleus with 2 red and green signals, ratio = 1; Magnification, ×60)).

References

    1. Hermanns B, Faridi A, Rath W, Füzesi L, Schröder W. Differential diagnosis, prognostic factors, and clinical treatment of proliferative Brenner tumor of the ovary. Ultrastruct Pathol. 2000;24:191–6. doi: 10.1080/01913120050132930. - DOI - PubMed
    1. Lee KR, Tavassoli FA, Prat J. Surface epithelial-stromal tumours. In: Tavassoli FA, Devilee P, editors. Pathology and Genetics: Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours 2003. Lyon: IARC Press; 2003. pp. 140–143.
    1. Cuatrecasas M, Catasus L, Palacios J, Prat J. Transitional cell tumors of the ovary: A comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol. 2009;33:556–67. doi: 10.1097/PAS.0b013e318188b84c. - DOI - PubMed
    1. Kondi-Pafiti A, Kairi-Vassilatou E, Iavazzo C, Vouza E, Mavrigiannaki P, Kleanthis C, Vlahodimitropoulos D, Liapis A. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors. Arch Gynecol Obstet. 2012;285:1699–702. doi: 10.1007/s00404-011-2182-5. - DOI - PubMed
    1. Kuhn E, Ayhan A, Shih IM, Seidman JD, Kurman RJ. The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis. Mod Pathol. 2014;27:231–7. doi: 10.1038/modpathol.2013.142. - DOI - PMC - PubMed

Publication types